UROGEN PHARMA LTD COM's ticker is URGN and the CUSIP is M96088105. A total of 5 filers reported holding UROGEN PHARMA LTD COM in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,607 | -44.7% | 302,124 | -9.4% | 0.01% | -16.7% |
| Q1 2022 | $2,905 | +63.8% | 333,472 | +78.8% | 0.01% | +140.0% |
| Q4 2021 | $1,774 | -56.8% | 186,493 | -23.6% | 0.01% | -50.0% |
| Q3 2021 | $4,107 | -15.0% | 244,165 | -22.8% | 0.01% | +11.1% |
| Q2 2021 | $4,829 | -15.1% | 316,248 | +8.4% | 0.01% | -18.2% |
| Q1 2021 | $5,686 | +327.8% | 291,870 | +295.7% | 0.01% | +175.0% |
| Q4 2020 | $1,329 | +101.4% | 73,769 | +115.6% | 0.00% | 0.0% |
| Q3 2020 | $660 | -46.5% | 34,212 | -27.5% | 0.00% | -69.2% |
| Q2 2020 | $1,233 | +311.0% | 47,208 | +180.6% | 0.01% | +85.7% |
| Q1 2020 | $300 | -43.9% | 16,821 | +5.0% | 0.01% | -46.2% |
| Q4 2019 | $535 | +57.8% | 16,025 | +12.6% | 0.01% | +85.7% |
| Q3 2019 | $339 | -30.2% | 14,235 | +5.2% | 0.01% | -41.7% |
| Q2 2019 | $486 | +45.9% | 13,529 | +50.2% | 0.01% | +20.0% |
| Q1 2019 | $333 | -31.5% | 9,007 | -20.3% | 0.01% | -50.0% |
| Q4 2018 | $486 | -8.6% | 11,298 | +0.4% | 0.02% | +25.0% |
| Q3 2018 | $532 | +13.2% | 11,258 | +19.3% | 0.02% | -5.9% |
| Q2 2018 | $470 | -30.0% | 9,438 | -30.1% | 0.02% | -48.5% |
| Q1 2018 | $671 | +94.5% | 13,502 | +45.4% | 0.03% | +22.2% |
| Q4 2017 | $345 | – | 9,284 | – | 0.03% | – |
Download | ||||||